MELTECH
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 30 Sept 2024)
What this means for you
Registered since 16 Oct 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87614404
- Registration number
- 5583912
- Mark type
- Stylized text
- Filed
- 19 Sept 2017
- Published for opposition
- 31 Jul 2018
- Registered
- 16 Oct 2018
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 005 — Pharmaceuticals: Tablets and medicaments for the treatment of genetic, [ cardiovascular, ] central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, [ dermatological, ] infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, [ ophthalmologic, ] psychiatric, respiratory, [ urogenital, urological, erectile dysfunction, sexual dysfunction, ] gynecology, obstetric, [ pediatric, hematologic, ] oncological, fungal and viral diseases and disorders
Owner
- Dexcel Pharma Technologies Ltd., Jerusalem, IL
- Dexcel Pharma Technologies Ltd., 3060000 Or Akiva, IL
- Dexcel Pharma Technologies Ltd., 3060000 Or Akiva, IL
Prosecution history
- 30 Sept 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Sept 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Sept 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Mar 2024 — TEAS SECTION 8 & 15 RECEIVED
- 16 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 31 Jul 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Jul 2018 — PUBLISHED FOR OPPOSITION
- 11 Jul 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Jun 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jun 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jun 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Jun 2018 — ASSIGNED TO LIE
- 11 Jun 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Dec 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED